PAYEE DETAILS Sample Clauses

PAYEE DETAILS. The Parties agree that the payee designated below is the proper payee for this Agreement, and that payments under this Agreement will be made only to the following payee (“Payee”):
Sample 1
AutoNDA by SimpleDocs
PAYEE DETAILS. The parties agree that the payee designated below is the proper payee for this agreement, and That payments under this agreement will be made only to the following payee (“payee) and will not violate any rules or policies of the healthcare provider, will not violate applicable national, state, or local laws or regulations. Banking Information: A. ÚDAJE O PŘÍJEMCI PLATEB: Smluvní strany se dohodly, že příjemce plateb uvedený níže je řádným příjemcem plateb podle této Smlouvy a že platby podle této Smlouvy budou prováděny pouze tomuto příjemci plateb (dále jen „Příjemce plateb“) a nebudou v rozporu s pravidly nebo směrnicemi Poskytovatele zdravotních služeb ani s příslušnými národními, státními nebo místními zákony a předpisy. Bankovní spojení: Bank Name Bank Street Bank City Bank State/Province Bank Postal Code Bank Country Receiving Account Currency IBAN Swift Code (8 or 11 Characters) Payee Name (Must match name in the contract) Payee Address Payee E-mail VAT/Tax ID (Tax ID must exactly match the payee name indicated above, or tax exempt when applicable) Příjemce plateb ze Smlouvy Jméno/název Příjemce plateb (musí odpovídat jménu/názvu ve smlouvě) Adresa Příjemce plateb E-mail Příjemce plateb DIČ (Daňové identifikační číslo musí odpovídat jménu výše uvedeného příjemce plateb; případně uveďte, že není plátcem DPH) Ulice Město Stát/kraj PSČ Země Měna účtu IBAN If the contracted Payment Currency does not match your bank account, you may need to provide an Intermediary Bank. Please contact your Financial institution for details. If an Intermediary bank is required, please provide Bank Name, Account Number if applicable and SWIFT Code of Intermediary Bank along with all other required Wire instructions Contact Information Name of recipient sending invoices to COMPANY Phone number & Email Name of payment recipient to receive payment notification and details Phone number & Email The Parties acknowledge that the designated Payee is authorized to receive all of the payments for the services performed under this Agreement. In case of changes in the Payee’s address or bank account number, Healthcare Provider is obliged to inform COMPANY in writing by sending an email to The parties agree that in case of changes in address which do not involve a change of Payee, tax numbers, or tax-exempt status, no further amendments are required. Payment to Investigator is determined by a separate agreement between Investigator and Company, which may involve different payment amoun...
Sample 1
PAYEE DETAILS. The Parties agrees that the payee designated below is the proper payee for this Agreement, and that payment under this Agreement to the payee designated below will not violate any rules or policies of the Institution, will not violate applicable national, state, or local laws or regulations, and that payment under this Agreement will be made only to the following payee (the “Payee”): PAYEE ADDRESS: 17. listopadu 1790/5, 000 00 Xxxxxxx-Xxxxxx, Xxxxx Xxxxxxxx PAYEE EMAIL ADDRESS xxxxxx.xxxxxxxx@xxx.xx BANK NAME Česká národní banka BANK XXXXXXX Xx Xxxxxxx 00, 000 00 Xxxxx 0 BANK ACCOUNT NUMBER 00000000/0710 IBAN NUMBER XX00 0000 0000 0000 0000 0000 SWIFT CODE / BRANCH CODE XXXXXXXX VARIABLE SYMBOL 649071221 VAT/GST/T AX ID NUMBER NA In case of changes in the Payee’s bank details, Institution is obliged to inform IQVIA in writing by sending an email to: XXX-XXXX@XXXXX.xxx. Institution shall contact its IQVIA study team member to provide signed documentation of changes to payee’s bank details. Parties agree that in case of changes in bank details which do not involve a change of payee or change of country location of bank account, no further amendments are required. A. ÚDAJE O PŘÍJEMCI PLATEB Název/jméno Příjemce plateb Fakultní nemocnice Ostrava
Sample 1
PAYEE DETAILS. The Parties agrees that the payee designated below is the proper payee for this Agreement, and that payment under this Agreement to the payee designated below will not violate any rules or policies of the Provider, will not violate applicable national, state, or local laws or regulations, and that payment under this Agreement will be made only to the following payee (the “Payee”): PAYEE NAME: Fakultní nemocnice v Motole PAYEE ADDRESS: V Úvalu 84, 150 06 Praha 5 Czech Republic SWIFT CODE / BRANCH CODE VAT/GST/TAX ID NUMBER , In case of changes in the Payee’s bank details, Provider is obliged to inform XXXXX in writing by sending an email to: XXX-XXXX@XXXXX.xxx. Provider shall contact its IQVIA study team member to provide signed documentation of changes to payee’s bank details. Parties agree that in case of changes in bank details which do not involve a change of payee or change of
Sample 1
PAYEE DETAILS. The Borrower hereby authorizes and directs FCC to pay the New Credit Facilities funds set out in paragraph 2.2 above as follows: Borrower Other Agricultural Purposes $2,970,000.00 (less solicitor fees of Xxxxxx Xxxxxxx LLP) FCC FCC – Credit Facility Processing Fee $30,000.00 The closing date for the New Credit Facilities is the 10th day of April, 2019, or such other date as may be agreed upon by the parties (the “Closing Date”). FCC may adjust the stipulated payments of principal and interest for the Credit Facilities with a variable interest rate, as a result of changes in the interest rate, to ensure that the principal outstanding is being paid as originally intended under this Agreement. Specific loan terms set out in Schedule B hereto are part of the New Credit Facilities.
Sample 1

Related to PAYEE DETAILS

  • Account Details (a) Account for delivery of Shares to Dealer: To be furnished (b) Account for delivery of Shares to Counterparty: To be furnished (c) Account for payments to Counterparty: To be advised under separate cover or telephone confirmed prior to each Settlement Date (d) Account for payments to Dealer: To be advised under separate cover or telephone confirmed prior to each Settlement Date

  • Payment Details payments due to the School by Parents under this agreement or from time to time due to the School by Parents must be made to the School paid by BACS to Widford Lodge School Ltd, Account number: 00000000, Sort Code: 60-05-13. The Parents should use the Child’s name as reference when making any payment.

  • Notice Details Party A: Swiss Re Financial Products Corporation Address: 55 East 52/nd/ Street 39/th/ Floor Xxx Xxxx XX 00000 XXX Xxxxxxxxx Xx.: +0 000 000 0000 Xxxxxxxxx: Head of Operations Xxxxx X: Permanent Financing (No. 6) PLC Address: Blackwell House Guildhall Yard Xxxxxx XX0X 0XX Xxxxxxxxx Xxxxxx: 000 0000 0000 Xxxxxxxxx: The Secretary With a copy to: (i) the Security Trustee:

  • Invoice Detail All charges for services rendered or for reimbursement of expenses authorized by Department pursuant to the Grant Work Plan shall be submitted to Department in sufficient detail for a proper pre-audit and post-audit to be performed. The Grantee shall only invoice Department for deliverables that are completed in accordance with the Grant Work Plan.

  • Contact details 9.1. Any notice, demand, offer or other written instrument required or permitted to be given pursuant to this Standard Transmission Agreement and to the Access Code for Transmission shall be sent to the contact persons mentioned in the contact details sheet as published on the Fluxys Belgium website. The duly filled contact details sheet will be added to attachment 1 of this Agreement. 9.2. Each Party may change these contact detail to which notice shall be sent, or specify one additional address to which copies of notices shall be sent, in accordance with the provisions of this Standard Transmission Agreement.

  • PRODUCT SUPPORT Partners may provide support for Products and other value-added services, and Partner is responsible for the performance of any services it provides. If Customer purchases Microsoft Support Services through a Partner, Microsoft will be responsible for the performance of those services subject to the terms of this Agreement.

  • Xxxxxxx Xxxxxxx Policy The terms of the Partnership’s xxxxxxx xxxxxxx policy with respect to Units are incorporated herein by reference.

  • Legal Details All legal details and proceedings in connection with the transactions contemplated by this Agreement and the other Loan Documents shall be in form and substance satisfactory to the Agent and counsel for the Agent, and the Agent shall have received all such other counterpart originals or certified or other copies of such documents and proceedings in connection with such transactions, in form and substance satisfactory to the Agent and said counsel, as the Agent or said counsel may reasonably request.

  • Project Number The project number has been assigned by the Commission as the unique identifier for your project, and it cannot be changed. The project number should appear on each page of the grant agreement preparation documents to prevent errors during its handling.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be submitted to the U.S. Food and Drug Administration (the “FDA”) or other comparable government entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes reasonably call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!